Replies to post #1816 on BioPharm Asia, Inc (fka BFAR)

[El_Lobo]

Combination of 1)their auditor not being licensed for about 2 years so all financials were in question, and 2) Switching out of all board executives with new ones, 3)Selling of Pharmacy subsidiary which brought in most of revenue

Those are the main ones imo